期刊文献+

骨肉瘤与血管内皮生长因子、基质金属蛋白酶2、9表达的相关性研究 被引量:5

The expression of vascular endothelial growth factor,matrix metalloproteinases 2,9 in osteosarcoma
下载PDF
导出
摘要 目的探讨骨肉瘤组织与血管内皮生长因子(VEGF)、基质金属蛋白酶(MMP)2、9表达的相关性及其对预后的影响,为骨肉瘤抗血管生成治疗的应用提供依据。方法采用免疫组织化学SP法对56例不同临床行为的骨肉瘤活检组织和8例转移灶组织进行VEGF、MMP-2、MMP-9表达的检测,并分析其与临床特点及预后的关系。结果经13~91个月随访,骨肉瘤患者3年无瘤生存率50.3%,5年无瘤生存率38.8%。MMP-2表达阳性率为53.6%,MMP-9表达阳性率为53.6%,VEGF高表达率为51.8%;MMP-2、MMP-9表达阳性和VEGF高表达与预后相关(P=0.0012、0.0049、0.0322)。MMP-2、MMP-9与VEGF的表达均有相关性(P=0.014、0.047)。COX比例风险模型分析影响骨肉瘤预后的因素有年龄(P=0.030)、MMP-2表达(P=0.024)和MMP-9表达(P=0.014),而性别、肿瘤大小、肿瘤亚型、手术方式和VEGF表达则与预后无关。骨肉瘤转移灶中MMP-2、MMP-9、VEGF表达阳性率较高,且同一病例原发灶与转移灶的表达有良好的一致性。结论骨肉瘤原发灶MMP-2、MMP-9表达提示肿瘤易于转移,患者预后差;骨肉瘤原发灶MMP-2、MMP-9表达与VEGF表达有相关性,提示前两者与VEGF在骨肉瘤转移过程的作用有关联;骨肉瘤转移灶MMP-2、MMP-9、VEGF表达阳性率较高。 Objective To investigate the expression of MMP-2, MMP-9 and VEGF in osteosarcoma and the correlation between VEGF and MMPs. Methods The expression of VEGF, MMP-2 and MMP-9 was detected by immunohistochemical method (S-P) in 56 patients of osteosarcoma including 8 with metastasis. The samples were collected from the primary osteosarcoma and the metastasis foci. Results The positive rates of MMP-2 and MMP-9 were 53.6% and 53.6%, respectively. And the high expression of VEGF was found in 51.8% of the cases. The clinical prognosis was associated with the positive expressions of MMP-2, MMP-9, and the high expression of VEGF by Log-Rank test. Moreover, the positive rates of MMP-2, MMP-9 and VEGF were higher in the metastasis foci than those in the primary tumors. In the same case, the expressions of MMP-2, MMP-9 and VEGF in the primary tumor were consistent with those in the metastasis foci, respectively. Kendall analysis indicated that the expressions of MMP-2 and MMP-9 were associated with the expression of VEGF in osteosarcoma. COX hazard regression analysis showed that: (1) sex, tumor size, tumor subtype, and the method of surgery were not related to prognosis; (2) the expression of MMP-2, MMP-9 in osteosarcoma and the age of patient were independently associated with poor prognosis and high rate of metastasis; (3) VEGF expression had no association with prognosis which was contradict with the result by Log-Rank test. Conclusion The high expressions of MMP-2 and MMP-9 in the primary osteosarcoma indicated high risk of metastasis and poor prognosis and the expressions of MMP-2 and MMP-9 were associated with that of VEGF expression.
出处 《浙江医学》 CAS 2006年第9期691-694,共4页 Zhejiang Medical Journal
关键词 骨肉瘤 血管内皮生长因子 基质金属蛋白酶 免疫组织化学 Osteosarcoma Vascular endothelial growth factor (VEGF) Matrix metalloproteinases (MMP) Immunohistochemistry
  • 相关文献

参考文献14

  • 1Himelstein B P, Asada N, Carlton M R, et al. Matrix metalloproteinase-9 (MMP-9) expression in childhood osseous osteosarcoma[J]. Med Pediatr Oncol, 1998,31(6):471-474.
  • 2Kaya M, Wada T, Akatsuka T, et al. Vascular endothelial growthfactor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis[J]. Clin Cancer Res, 2000,6(2):572-577.
  • 3华成舸,温玉明,王昌美,李龙江.骨和软组织肿瘤中明胶酶的定位与活性分析[J].华西医科大学学报,2000,31(1):82-85. 被引量:10
  • 4E1-Shabrawi Y, Ardjomand N, Radner H, et al. MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma[J]. J Pathol, 2001 , 194(2): 201-206.
  • 5Bergers G, Brekken R, McMaho G, et al. MMP and triggers the angiogenesis switch during carcinbogenesis[J]. Nat Cell Biol, 2000,2(10):737-744.
  • 6Fang J, Shing Y, Wiederschain D, et al. Matrix metalloproteinase 2 is required for the switch to the angiogenic phenotype in a tumor model[J]. Proc Natl Acad Sci USA, 2000,97(8):3 884-3889.
  • 7Kumaki F, Matsui K, Kawai T, et al. Expression of matrix metalloproteinases in invasive pulmonary adenocarcinoma with bronchioloalveolar component and a typical adenomatous hyperplasia[J].Am J Pathol , 2001,159(6):2 125-2 135.
  • 8Kawata R, Shimada T, Maruyama S, et al. Enhanced production of matrix metalloproteinase-2 in human head and neck carcinomas is correlated with lymph node metastasis [J]. Acta Otolaryngol,2002,122(1): 101-106.
  • 9Maeta H, Ohgi S, Terada T. Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas[J]. Virchows Arch, 2001,438(2): 121-128.
  • 10Papadopoulou S, Seorilas A, Amogianaki N, et al. Expression of gelatinase-A (MMP-2) in human colon cancer and normal colon mucosa[J]. Tumour Biol, 2001, 22(6):383-389.

二级参考文献1

  • 1Bian J H,Mol Cell Biol,1997年,17卷,11期,6330页

共引文献9

同被引文献82

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部